ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO

ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO
ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO
by is licensed under

All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities. Additional production facilities are planned to meet the expected supply short fall in the Canadian market when marijuana for recreational use is legalized next year. With its state-of-the-art cultivation facilities and established patient-client care systems, ABcann has the infrastructure in place to profit from that billion-dollar Canadian marijuana market.

With adult use of marijuana set for legalization by July 1, 2018, the Canadian marijuana market is expected to expand to $8 billion by 2024, according to Canada’s largest independent investment dealer, Canaccord Genuity Group. This puts it on par with the beer and tobacco markets in Canada. Canadians spend about $9 billion on beer and over $10 billion on cigarettes every year.

Read the full article

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Tags
Growers/Producers, Marijuana Investing
Thumbnail Photo Credit: by is licensed under